Artificial Intelligence You Can Trust: What Matters Beyond Performance When Applying Artificial Intelligence to Renal Histopathology?

John O O Ayorinde, Federica Citterio, Matteo Landrò, Elia Peruzzo, Tuba Islam, Simon Tilley, Geoffrey Taylor,Victoria Bardsley,Pietro Liò,Alex Samoshkin,Gavin J Pettigrew

Journal of the American Society of Nephrology : JASN(2022)

引用 3|浏览1
暂无评分
摘要
Although still in its infancy, artificial intelligence (AI) analysis of kidney biopsy images is anticipated to become an integral aspect of renal histopathology. As these systems are developed, the focus will understandably be on developing ever more accurate models, but successful translation to the clinic will also depend upon other characteristics of the system.In the extreme, deployment of highly performant but "black box" AI is fraught with risk, and high-profile errors could damage future trust in the technology. Furthermore, a major factor determining whether new systems are adopted in clinical settings is whether they are "trusted" by clinicians. Key to unlocking trust will be designing platforms optimized for intuitive human-AI interactions and ensuring that, where judgment is required to resolve ambiguous areas of assessment, the workings of the AI image classifier are understandable to the human observer. Therefore, determining the optimal design for AI systems depends on factors beyond performance, with considerations of goals, interpretability, and safety constraining many design and engineering choices.In this article, we explore challenges that arise in the application of AI to renal histopathology, and consider areas where choices around model architecture, training strategy, and workflow design may be influenced by factors beyond the final performance metrics of the system.
更多
查看译文
关键词
AI,arteriosclerosis,artificial intelligence,glomerulosclerosis,interstitial fibrosis,kidney biopsy,renal fibrosis,renal pathology,renal transplantation,transplant pathology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要